{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:32:27Z","timestamp":1784122347890,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease and other dementias (ADOD) pose a significant and escalating global public health challenge, particularly among the aging populations. Emerging evidence has identified high fasting plasma glucose (HFPG) as a major modifiable risk factor for ADOD, linking impaired glucose metabolism to cognitive decline and neurodegeneration. Despite this association, the comprehensive impact of HFPG on the global burden of ADOD has not been fully elucidated. Understanding the extent to which HFPG contributes to ADOD is crucial for developing targeted interventions and optimizing healthcare resource allocation to address this growing concern.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using Global Burden of Disease data (GBD 2021), we analyzed the global HFPG-related ADOD burden from 1990 to 2021 using an age-period-cohort framework and predicted trends for 2050. A Shiny platform was developed to visualize the disease burden and trends across 204 countries and regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2021, approximately 15% of ADOD deaths and disability-adjusted life years (DALYs) were attributed to HFPG, a 271.05% increase from 1990. The incidence rate rose from 47.07 to 66.42, indicating poor control. The mortality rate from HFPG-ADOD increased by 305.81%. The primary burden was among the 80\u201384 age group. Trends in ASDR and ASMR showed an increase across most SDI regions, except Low SDI. Decomposition analysis and the APC model indicated poor control in high SDI regions due to aging populations over the past 5\u202fyears. By 2050, the global prevalence is projected to reach 1,003,018.047 (26124.40377, 12114480.49), with 345,342.5738 (1431.57781, 6022119.213) males and 657,675.4731 (24692.82596, 6092361.28) females. The Shiny platform predicts a yearly increase in ASDR and ASMR for HFPG-ADOD in China, which is consistent with GBD platform trends. The platform is accessible at <jats:ext-link>http:\/\/116.196.73.86:3838\/GBD\/HFPG-ADOD\/<\/jats:ext-link>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The global burden of HFPG-related ADOD has been increasing, even in high SDI regions, over the past 5\u202fyears and is expected to continue rising until 2050. Implementing appropriate health policies to mitigate this trend could significantly reduce the substantial burden caused by HFPG-induced ADOD. Promoting the use of the Shiny prediction platform will contribute significantly to global healthy aging.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1516267","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:18:04Z","timestamp":1738732684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic analysis and prediction of the burden of Alzheimer\u2019s disease and other dementias caused by hyperglycemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Dongying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref1","first-page":"11","article-title":"Alzheimer's disease and other dementias in Canada","volume":"27","author":"Wong","year":"2016","journal-title":"Health Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"230404116","DOI":"10.1177\/15333175211044884","article-title":"Trends in mortality rates for Alzheimer's disease and other dementias over 30 years in China","volume":"36","author":"Bai","year":"2021","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: a population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"Am J Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.2040-1124.2012.00234.x","article-title":"Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline?","volume":"3","author":"Kawamura","year":"2012","journal-title":"J Diabet Invest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7762\/cnr.2018.7.4.229","article-title":"Diabetes and Alzheimer's disease: mechanisms and nutritional aspects","volume":"7","author":"Lee","year":"2018","journal-title":"Clin Nut Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet (London, England)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","article-title":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the global burden of disease study 2020","volume":"400","year":"2022","journal-title":"Lancet (London, England)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Collaborators","year":"2020","journal-title":"Lancet (London, England)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e3572","DOI":"10.1002\/dmrr.3572","article-title":"The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: an updated analysis for the global burden of disease study 2019","volume":"38","author":"Liang","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ije\/dyaa196","article-title":"Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study","volume":"50","author":"Liu","year":"2021","journal-title":"Int J Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","article-title":"Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study","volume":"8","author":"Du","year":"2020","journal-title":"Biomark Res"},{"key":"ref16","author":"Chang","year":"2024"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age\u2013period\u2013cohort analysis with integrated nested Laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the {tidyverse}","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Sour Softw"},{"key":"ref19","author":"Kassambara","year":"2020"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot 2: Elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.3390\/ijms232315287","article-title":"Type 2 diabetes mellitus and Alzheimer's disease: shared molecular mechanisms and potential common therapeutic targets","volume":"23","author":"Hamz\u00e9","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.3390\/ijms22158142","article-title":"Brain glucose transporters: role in pathogenesis and potential targets for the treatment of Alzheimer's disease","volume":"22","author":"Szablewski","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.dsx.2016.01.021","article-title":"Shared links between type 2 diabetes mellitus and Alzheimer's disease: a review","volume":"10","author":"Mittal","year":"2016","journal-title":"Diabet Metab Synd"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","article-title":"Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer cohorts consortium","volume":"95","author":"Wolters","year":"2020","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.arcmed.2012.10.006","article-title":"The macroeconomics of dementia--will the world economy get Alzheimer's disease?","volume":"43","author":"Banerjee","year":"2012","journal-title":"Arch Med Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.14283\/jpad.2023.57","article-title":"Are population-level approaches to dementia risk reduction under-researched? A rapid review of the dementia prevention literature","volume":"11","author":"Walsh","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.2337\/dc21-2100","article-title":"Trends in prevalence and awareness of prediabetes among adults in the U.S., 2005-2020","volume":"45","author":"Xia","year":"2022","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.amepre.2018.05.018","article-title":"Trends in the prevalence of diabetes among U.S. adults: 1999-2016","volume":"55","author":"Fang","year":"2018","journal-title":"Am J Prev Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.14283\/jpad.2021.69","article-title":"Disease burden and attributable risk factors of Alzheimer's disease and dementia in China from 1990 to 2019","volume":"9","author":"Li","year":"2022","journal-title":"J Prev Alzheimers Dis"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1516267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:18:08Z","timestamp":1738732688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1516267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2024.1516267"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1516267","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1516267"}}